Control of Brain Development, Function, and Behavior by the Microbiome  by Sampson, Timothy R. & Mazmanian, Sarkis K.
Cell Host & Microbe
ReviewControl of Brain Development, Function,
and Behavior by the MicrobiomeTimothy R. Sampson1 and Sarkis K. Mazmanian1,*
1Division of Biology & Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
*Correspondence: sarkis@caltech.edu
http://dx.doi.org/10.1016/j.chom.2015.04.011
Animals share an intimate and life-long partnership with a myriad of resident microbial species, collectively
referred to as themicrobiota. Symbiotic microbes have been shown to regulate nutrition andmetabolism and
are critical for the development and function of the immune system. More recently, studies have suggested
that gut bacteria can impact neurological outcomes—altering behavior and potentially affecting the onset
and/or severity of nervous system disorders. In this review, we highlight emerging evidence that the micro-
biome extends its influence to the brain via various pathways connecting the gut to the central nervous sys-
tem. While understanding and appreciation of a gut microbial impact on neurological function is nascent,
unraveling gut-microbiome-brain connections holds the promise of transforming the neurosciences and
revealing potentially novel etiologies for psychiatric and neurodegenerative disorders.Introduction
Metazoans evolved in a world dominated by microbial life.
Despite the long evolutionary history that has forged elaborate
host-microbial symbioses over many millennia, it is only recently
that science and society have begun to appreciate the inextri-
cable connection between microbes and mammals. We are wit-
nessing a groundswell of research that is describing and defining
how gut bacteria (known as the microbiota) influence critical as-
pects of our physiology. The last decade of research has illumi-
nated numerous complex interactions between the microbiota
and the immune and metabolic systems, many of which have
significant implications on human health. While the fascinating
and profound mechanisms by which gut bacteria control immu-
nity andmetabolism has led to a modern renaissance in biomed-
ical research, regulation of the nervous system by the microbiota
had remained relatively unexplored until very recently (Mayer
et al., 2014, 2015; Stilling et al., 2014b). How could simple gutmi-
crobes influence a complex and distant organ such as the brain?
This seemingly improbable concept that specific microbes influ-
ence the behavior and neurological function of their hosts had, in
fact, already been established. One prime example of ‘‘microbial
mind control’’ is the development of aggression and hydropho-
bia in mammals infected with the rabies virus (Driver, 2014).
Another well-known example of behavior modification occurs
by Toxoplasma gondii, which alters the host rodents’ fear
response. Infected rodents lose their defensive behavior in the
presence of feline predators and instead actually become sexu-
ally attracted to feline odors (House et al., 2011). This results in
infected rodents being preyed upon more readily by cats and al-
lows Toxoplasma to continue its lifecycle in the feline host
(House et al., 2011). Further, a variety of parasitic microbes are
capable of altering the locomotive behavior and environmental
preferences of their hosts to the benefit of the microbe. For
instance, the Spinochordodes tellinii parasite causes infected
grasshopper hosts to not only jump more frequently but also
seek an aquatic environment where the parasite emerges to
mate and produce eggs (Biron et al., 2005). Temperature prefer-
ence of the host can even be altered, such as observed duringinfection of stickleback fish by Schistocephalus solidus, which
changes the hosts’ preference from cooler waters to warmer wa-
ters where the parasite can grow more readily (Macnab and
Barber, 2012). Other microbes can even alter host behavior to
seek higher elevations, believed to allow the infected host to
be noticed more easily by predators or to eventually fall and
disperse onto susceptible hosts below (Maitland, 1994). More
coercively still, microbes can influence the social behavior of
their hosts, causing insects, such as ants, to become more or
less social to the benefit of the parasite (Hughes, 2005). In fact,
the sexually transmitted virus IIV-6/CrIV causes its cricket host
(Gryllus texensis) to increase its desire to mate, causing its rate
of mating to be significantly elevated and allowing for transmis-
sion between individual hosts (Adamo et al., 2014).
While all of the above examples most certainly represent path-
ogenic and/or parasitic relationships, they nonetheless raise the
possibility that the indigenous microbes, which are in constant,
life-long interaction with their human and animal hosts, could in-
fluence neurological function and behavior during development
or within health and disease states. It is becoming increasingly
recognized that psychiatric and neurological illnesses are often
co-morbid with gastrointestinal (GI) pathology (Vandvik et al.,
2004), including schizophrenia, autism, neurodegenerative dis-
eases, and depression. Furthermore, recent observations have
indicated that the commensal microbiota of the intestine do
indeed alter aspects of their hosts’ neurological function, leading
to effects on mood and behavior, including depression, anxiety,
social behavior, and mate choice (Table 1) (Bravo et al., 2011;
Desbonnet et al., 2010; Foster and McVey Neufeld, 2013; Hsiao
et al., 2013; Neufeld et al., 2011; Sharon et al., 2010). The intes-
tinal microbiota are, however, well established to have a pro-
found impact in shaping the host immune system, which itself
may subsequently influence host behavior (Dantzer et al.,
2008) and indirectly have effects on neurodegeneration and
repair during the process of aging, neurological trauma, and dis-
ease. The precise mechanisms of how the intestinal microbes
impact neurological function and behavior remain largely un-
known, but are likely vast, varied, and complex.Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc. 565
Table 1. Selected Phenotypic Attributes Influenced by Gut Microbes
Category Attribute Effect Citation(s)
Behavioral Anxiety Reduced self-reported anxiety in humans
treated with L. helveticus R0052 and B. longum
R0175
Messaoudi et al., 2011
Behavioral Anxiety-like behavior Decreased anxiety-like behavior in GF mice
(Swiss Webster, NIH Swiss, and NMRI)
Clarke et al, 2013; Diaz Heijtz et al., 2011;
Neufeld et al., 2011; Selkrig et al., 2014
Behavioral Anxiety-like behavior Increased anxiety-like behavior in GF mice
(BALB/c, C57Bl6)
Bercik et al., 2011; Selkrig et al., 2014
Behavioral Anxiety-like behavior Reduced anxiety-like behavior in rodents
treated with Bifidobacterium breve 1205,
B. longum 1714, B. longum R0175
Lactobacillus helveticus R0052, or
L. rhamnosusJB-1
Bravo et al., 2011; Messaoudi et al., 2011;
Savignac et al., 2014
Behavioral Depression Reduced self-reported feelings of depression
and aggression in humans treated with
probiotics
Steenbergen et al., 2015
Behavioral Depression-like behavior Decreased depression-like behavior in mice
treated with B. infantis or L. rhamnosus JB-1
Bravo et al., 2011; Desbonnet et al., 2010;
Savignac et al., 2014; Savignac et al., 2015
Behavioral Emotional processing Reduced activation following emotional
stimulus in humans treated with probiotic milk
product
Tillisch et al., 2013
Behavioral Social recognition Reduced novel and familiar social recognition in
GF mice
Desbonnet et al., 2014
Behavioral Stereotyped behaviors
and vocalizations
Restoration of social behaviors in Bacteroides
fragilis-treated MIA mice
Hsiao et al., 2012
Behavioral Stress response Increased response to restraint stress in
GF mice
Sudo et al., 2004
Hormonal Corticosterone Increased hypothalmic corticosterone in
GF mice
Sudo et al., 2004
Hormonal Cortisol Reduced urinary cortisol in humans treatedwith
L. helveticus R0052 and B. longum R0175
Messaoudi et al., 2011
Neurochemical BBB Decreased expression of tight junction
proteins, and subsequent increase of BBB
permeability
Braniste et al., 2014
Neurochemical BDNF Decreased hypothalmic BDNF in GF mice Sudo et al., 2004
Neurochemical Dopamine and GABA Decreased serum levels of dopamine and
GABA in GF mice
Matsumoto et al., 2012;
Velagapudi et al., 2010
Neurochemical G-CSF Reduced serum levels of G-CSF in GF mice Deshmukh et al., 2014
Neurochemical Peripheral serotonin Decreased peripheral and intestinal serotonin
in GF mice, restored by colonization with spore
forming bacteria
Wikoff et al., 2009; Yano et al., 2015
Neurochemical Serotonin and Serotonin
receptor
Decreased serotonin and receptor (5HT1A) in
the amygdala and hippocampus of GF mice
Bercik et al., 2011; Clarke et al., 2013;
Diaz Heijtz et al., 2011; Neufeld et al., 2011;
Yano et al., 2015
Neurochemical Serotonin, noradrenaline,
and dopamine
Increased turnover of serotonin, noradrenaline,
and dopamine in the striatum of GF mice
Diaz Heijtz et al., 2011
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intricate. Intestinal microbes influence numerous aspects of
metabolism, producing metabolic precursors to hormones and
neurotransmitters or directly producing the active metabolites
themselves (Lyte, 2014; Sharon et al., 2014) (Figure 1). Symbiotic
bacteria additionally have the capability to influence the status of
the systemic immune system, which may alter how the immune
system subsequently interacts with the nervous system (Belkaid
and Hand, 2014; Hooper et al., 2012; Round and Mazmanian,
2009) (Figure 1). Furthermore, the enteric nervous system (ENS)566 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.is directly connected to the central nervous system (CNS) through
the vagus nerve, providing a direct neurochemical pathway
for microbial-promoted signaling in the GI tract to be propagated
to the brain (Forsythe et al., 2014) (Figure 1). Herein, we review
the current understanding of how the intestinal microbiota
influence behavior and neurological function during both health
and disease. First, we will focus on how indigenous microbes
shapemood and cognitive behaviors, as well as social behaviors.
Wewill next discuss the physiological aspects that aremodulated
by signals derived from the microbiota. In particular, we will
Figure 1. Pathways Linking the Microbiome and CNS
Signals from the intestinal microbiome may potentially traffic to the CNS via
several mechanisms: (1) direct activation of the vagus nerve from the ENS to
the CNS; (2) production of, or induction of, various metabolites that pass
through the intestinal barrier and into the circulatory system, where they may
cross the BBB to regulate neurological function; (3) and MAMPs (such as LPS,
BLP, and PSA) and metabolites produced by the microbiota can signal to the
immune system. Immune cells (and particularly their cytokines) can influence
neurophysiology.
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shape neurochemical and immunologic responses that can sub-
sequently affect behaviors and other neurological functions
(Table 1). With well-documented evidence that the microbiota
shape immunity and metabolism, the impact of gut microbes on
the nervous system represents an exciting new frontier for
research with vast translational implications.
Role of the Microbiota in Mood and Individual Behaviors
One of the seminal studies on the influence of the commensalmi-
crobiota on neurological function observed that germ-free (GF)
mice display an elevated response to restraint stress, the stress
that occurs during forced immobilization (Sudo et al., 2004). In
the absence of the microbiota, mice have substantially higher
concentrations of corticosterone, a stress hormone in the hypo-
thalamus, as well as reduced levels of brain-derived neurotro-
phic factor (BDNF; a protein that stimulates neurogenesis, stim-
ulates synaptic growth, and modulates synaptic plasticity and
transmission) (Lu et al., 2013; Sudo et al., 2004). Interestingly,
this phenomenon can be partially reversed by re-colonization
with a diverse microbiota in adulthood, suggesting that active
signals from the microbiota play a critical role in brain develop-
ment. In fact, colonization with a specific bacterial species,
Bifidobacterium infantis, restores the defect (compared to
monocolonization with Esherichia coli), demonstrating that
rather than the general sensing of the bacteria within the popula-
tion of indigenous microbes, signals from specific bacteria drive
normal behavior (Sudo et al., 2004). This rigorous demonstration
that the microbiota affects the hypothalamic–pituitary–adrenal
axis (HPA axis) revealed bi-directional communication between
the gut and the brain, with a significant effect on host behavior.
Conversely, in the absence of restraint stress, some strains
of GF mice (Swiss Webster, NIH Swiss, and NMRI) displaydecreased anxiety-like behavior, in the form of increased explo-
ration compared to specific pathogen-free (SPF) mice, which are
colonized with a diverse microbial population. For instance, GF
mice spend more time in the lighted section of a light-dark
box, as well as the open arms of an elevated plus-maze, than
their colonized counterparts, evidence of decreased anxiety-
like behavior, as mice typically desire to be in a closed, dark
area (Clarke et al., 2013; Diaz Heijtz et al., 2011; Neufeld et al.,
2011; Selkrig et al., 2014). Importantly, these behavioral effects
can be restored to levels similar to conventionally raised mice
by recolonizing the GF mice with a complete SPF microbiota.
The effect of the microbiota is not necessarily consistent across
all strains of mice. For instance, SPF BALB/c and C57Bl6 mice
display increased anxiety behavior compared to other strains,
such as NIH Swiss mice (Bercik et al., 2011; Selkrig et al.,
2014). The microbiome present in BALB/c mice is significantly
different than that present in NIH Swiss mice. When fecal micro-
biota from either strain are transplanted into GF mice of the
counterpart strain, the behavior of the parent strain is transferred
(Bercik et al., 2011). This interesting finding implicates that sig-
nals derived from the microbiota can drive behaviors in the
host. Further, phenotypic changes following fecal microbiota
transplants in adult mice reveal that anxiety can be actively
modulated by the microbial population and are not necessarily
developmental in origin. It is therefore interesting to contemplate
that activemodulation of the population or function of the gut mi-
crobiota, such as through probiotic supplementation, may act to
modify host stress and anxiety behaviors as well. In fact, there is
an active and growing line of observations of the effect of probi-
otic species on the behavior of the host.
In one such probiotic supplementation study, it was observed
that mice given the probiotic bacterium Lactobacillus rhamnosus
(JB-1) over a 28 day period displayed decreased anxiety-like
behavior in the elevated plus maze and open-field test (Bravo
et al., 2011). Additionally, the effect of L. rhamnosus on anxiety
behavior is ameliorated in mice that have been vagotomized
and lack connectivity of the vagus nerve between the ENS and
the CNS (Bravo et al., 2011). This would suggest that microbial
signals can be directed by the vagus nerve to alter CNS outputs
(such as behavior), further implicating an active role by themicro-
biota in mediating neurological functions. In a similar fashion,
treatment with B. longum 1714 and B. breve 1205 was observed
to decrease anxiety-like behaviors to the same extent as the
pharmaceutical anti-anxiety medication escitalopram (Savignac
et al., 2014). Other studies in rats utilizing a probiotic cocktail of
L. helveticus R0052 and B. longum R0175 found that treatment
with these microbes over a 30 day period resulted in decreased
anxiety in an electric shock model, further suggesting that the
functionality of the gut microbiota influences anxiety-like behav-
iors (Messaoudi et al., 2011). Together, these studies provide
credence to the intriguing hypothesis that active modulation of
the intestinal microbiota, through probiotic supplementation,
can have drastic effects on behavior, perhaps with therapeutic
potential.
Anxiety is not the only behavior that is modulated by signals
from symbiotic bacteria. The same study that utilized the probi-
otic L. rhamnosus (JB-1) to treat mice also observed that these
mice displayed decreased depression-like behaviors, particu-
larly in the forced swim test (Bravo et al., 2011). ProbioticCell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc. 567
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when introduced into a water-filled cylinder, rather than attempt
to swim. In a similar fashion, a separate study utilized the
maternal separation model of depression in rats, in which pups
are removed from their mothers for a period of time each day un-
til weaning (Vetulani, 2013). This study noted that the depres-
sion-like behaviors induced in this model could be reduced
upon treatment with B. infantis (Desbonnet et al., 2010). Strik-
ingly, B. infantis treatment resulted in a similar reduction in
depression-like behavior in the forced swim test as was
observed upon treatment with the pharmaceutical antidepres-
sant citalopram, a selective serotonin reuptake inhibitor (SSRI)
(Desbonnet et al., 2010; Savignac et al., 2014, 2015). These sur-
prising findings further suggest that the composition and/or
function of the microbiota actively modulates behavior in adult
animals.
Intriguingly, probiotic supplementation, or even diet alone, are
observed to have an impact on both anxiety and depressive
behavior in mice, as well as on learning and memory (Li et al.,
2009; Pyndt Jørgensen et al., 2014; Savignac et al., 2015). While
some studies have also demonstrated that specific diets alter the
composition of the microbiome and have effects on behaviors,
whether the microbial composition itself is causative for the
observed depressive-behavior and learning deficits observed
in these studies is not clear (Li et al., 2009; Pyndt Jørgensen
et al., 2014). Functional studies utilizing transplantation of diet-
altered microbiomes would be essential to establish a microbial
role. Nonetheless, such observations serve to pave the way
toward understanding the role that the composition and func-
tionality of indigenous microbes may play in shaping mood and
behavior in the host.
While most studies have utilized animal models, work is being
performed to understand whether the microbiota have similar
roles in shaping human neurological function. A recent human
study was performed to address whether the consumption of a
fermented, probiotic milk product (containing B. animalis subsp
Lactis, Streptococcus thermophilus, L. bulgaricus, and Lacto-
coccus lactis subsp Lactis.) could have an effect on the brain
response to emotional stimuli. Using fMRI, Mayer and col-
leagues found that probiotic consumption over the span of
4 weeks could affect the processing of emotion (Tillisch et al.,
2013). Specifically, those regions of the brain involved in
emotional processing, including the primary interoceptive and
somatosensory regions, were less activated following emotional
stimulation (emotional faces task) in those individuals who had
consumed this probiotic product (Tillisch et al., 2013). Similarly,
a separate study observed that probiotic consumption reduced
self-reported feelings of sadness and aggressive thoughts
(Steenbergen et al., 2015). Importantly, while these particular
studies were small and did not address exactly how the bacterial
cocktail mediated changes in functional brain activity andmood,
they are nonetheless strongly suggestive that themicrobiota can
actively alter some functional aspects of mood in humans. A
larger human study of 55 individuals examined whether probiotic
consumption could influence anxiety (through self-assessment
questionnaires) (Messaoudi et al., 2011). Administration of
L. helveticus R0052 and B. longum R0175 resulted in decreased
self-reported anxiety and, notably, also resulted in decreased
urinary cortisol (Messaoudi et al., 2011). Together, these studies568 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.further the concept that themicrobiota effects neurological func-
tion in humans and ultimately influences mood and behavior.
However, additional work with increased cohort sizes, using a
crossover study design and clinical assessment, are needed to
validate these seminal observations for a gut-microbiome-brain
connection in humans.
Interestingly, it has been observed in both humans and mice
that probiotic supplementation with fermented dairy products
does not necessarily alter the composition of the gutmicrobiome
(McNulty et al., 2011). Instead, the transcriptional state and/or
metabolic activity of the microbiota are altered (McNulty et al.,
2011). It is therefore interesting to consider that these behavioral
and neurological changes may not necessarily be a direct func-
tion of the specific species of bacteria within the probiotic treat-
ment; rather, microbial-mediated effects on emotion may be
due to broader functionality of the community of symbiotic bac-
teria within the gut. Continued study of how the presence of spe-
cific bacterial species, particularly low abundance niche species,
influences physiology but does not alter the overall population of
gut microbes, will be critical to understanding the function of the
microbiota and how they can be effectively harnessed and devel-
oped as apotential therapeuticmodality for behavioral disorders.
One well-established physiological function of the microbiota
is the generation of essential nutrients for host physiology,
such as vitamins and other cofactors (Gordon et al., 2012).
Therefore, it is tempting to speculate that perhaps these mi-
crobes could subsequently alter satiety, influencing how much
food the host ingests. While there is no unequivocal evidence
demonstrating that the microbiota directly influence appetite
and satiety, there are intriguing indirect observations. Upon
ingestion of fermentable complex carbohydrates, the microbiota
metabolize fiber into short-chain fatty acids (SCFAs) such as ac-
etate, butyrate, and propionate (Miller andWolin, 1979). Interest-
ingly, SCFAs produced in the GI tract are trafficked not only into
the serum, but also are capable of crossing the blood-brain bar-
rier (BBB) (Conn et al., 1983; Mitchell et al., 2011). Once in the
brain, one particular SCFA, acetate, has been observed to enact
physiological changes in the hypothalamus. Here, acetate alters
the level of the neurotransmitters glutamate, glutamine, and
g-aminobutyric acid (GABA) as well as increases anorectic neu-
ropeptide expression (Frost et al., 2014), which together act as
hormone signals to reduce appetite (Sobrino Crespo et al.,
2014). In total, production of acetate leads to suppression of
appetite. In fact, a small study in humans found that fermentation
of complex carbohydrates to SCFAs by the microbiota was
directly correlated with the sensation of satiety (Cani et al.,
2009), providing a basis for the hypothesis that the symbiotic
microbes may be capable of modulating host appetite. Indeed,
changes to the microbiome, due to a specific genetic mutation
in mice, induce a metabolic syndrome, likely through changes
in feeding behaviors rather than alterations to metabolism
(Vijay-Kumar et al., 2010).
Microbiota Shape Social Behaviors
Numerous facets of social behavior are also altered by the pres-
ence, composition, and functionality of the microbiota (Mayer
et al., 2015; Stilling et al., 2014b). GF mice are significantly so-
cially impaired compared to SPF colonized counterparts (Des-
bonnet et al., 2014). GF mice do not seek out other mice (both
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consortium (Desbonnet et al., 2014), suggesting that the micro-
biota affect these social behaviors. Surprisingly, social avoid-
ance could be restored through recolonizing adult mice with a
complete microbiota. Conversely, the defect in social cognition
(that is, the ability to recognize familiar versus unfamiliar mice)
was not restored following colonization. Thus, gut bacteria
have differential effects on both developmental aspects, as
well as active processes that occur in adulthood, which ulti-
mately shape long-term behavioral traits (Desbonnet et al.,
2014).
One particularly interesting example of microbiome-controlled
social behavior is that of sexual mate preference in the fruit fly,
Drosophila melanogaster. Flies that have been colonized with
L. plantarum prefer to mate only with similarly colonized flies,
and not with flies colonized by other bacterial species (Sharon
et al., 2010). This is due to the increased production of certain
pheromones whose precursors are produced by L. plantarum
within these flies. As such, this provides a strong, mechanistic
example to begin to understand how the microbiome can influ-
ence the extremely complex social behavior of mate preference
(Sharon et al., 2010). Building on this, an interesting study of
social behaviors in hyenas found that individual social groups
of these animals harbored distinct microbiota within their scent
glands (Theis et al., 2012, 2013). Scent-gland dwelling symbi-
otic bacteria are known to produce volatile compounds, and
each unique microbial community produces different ratios of
these compounds (Theis et al., 2012, 2013). As distinct social
groups had similar microbiomes, individuals likely are recog-
nized as belonging to a particular social group directly due to
the composition of the microbes within their glands. These
studies provide support for the notion that symbiotic bacteria
affect how a host interacts in social settings, modulating how
the host perceives novel versus familiar individuals for both
mate choice and social grouping. The ramifications of this
microbial influence on social behaviors has not gone unnoticed
by evolutionary biologists (Montiel-Castro et al., 2014; Rosen-
berg et al., 2010; Stilling et al., 2014a). If gut bacteria modulate
neurological function leading to the choice of mate, the micro-
biome may therefore play a significant role in driving the evolu-
tion of their hosts. By influencing how individuals interact and
undergo vertical genetic transfer, the microbiota could ulti-
mately be a critical contributing factor in the evolution of meta-
zoan species.
The Link between Gut Bacteria and Disorders Involving
Social Impairment
Autism spectrum disorder (ASD) comprises a set of complex
neurodevelopmental disabilities characterized by repetitive/ste-
reotypic behaviors and deficits in communication and social
interaction. Intriguingly, a significant subset of ASD children
exhibit GI complications, including constipation, increased in-
testinal permeability, and altered composition of the intestinal
microbiome (Kang et al., 2013; Mulle et al., 2013; Rosenfeld,
2015). Mice displaying autism-like behaviors have a significantly
altered microbiome compared to neurotypical controls; have an
increase in the permeability of the colon; and, correlatively,
display differences in serummetabolites (Hsiao et al., 2013). Sur-
prisingly, treatment with a single organism, Bacteroides fragilis,was able to restore the intestinal permeability defects in a mouse
model of ASD (Hsiao et al., 2013). While treatment with this
probiotic did not restore the overall composition of the microbial
population, B. fragilis treatment could restore levels of a small
number of specific species (Hsiao et al., 2013). Notably,
B. fragilis treatment rescued some behavioral defects, including
stereotyped behavior (compulsive marble burying), communica-
tion deficits (ultrasonic vocalizations), and anxiety behaviors
(open-field exploration) (Hsiao et al., 2013).
B. fragilis has been shown to augment the development and
function of the immune system (Mazmanian et al., 2008;
Ochoa-Repa´raz et al., 2010; Round and Mazmanian, 2010);
however, treatment with B. fragilis did not restore several as-
pects of immune dysfunction in an animal model of autism (Hsiao
et al., 2012, 2013). Instead, levels of serum metabolites found to
be altered in mice with ASD-related behaviors were restored to
normal levels. Administration to healthy animals of a specific
serum metabolite that was elevated in mice with behavioral
deficits, namely 4-ethylphenyl sulfate (4EPS), was sufficient to
induce anxiety-like behavior. As 4EPS is predicted to be of mi-
crobial origin, this remarkably demonstrates that defined mole-
cules from the microbiome can impact behavior in mammals.
Similarly, another study demonstrated that mice with features
of ASD display a significantly altered microbiome and increased
intestinal inflammation (de Theije et al., 2014). Although still
correlative, these data together suggest that certain neurodeve-
lopmental disorders, such as autism, may have microbial etiol-
ogies, a hypothesis that will require further validation in both
animal models and human trials. The notion that the gut micro-
biome constitutes an environmental risk factor for autism is sup-
ported by epidemiologic studies showing a rapid increase in
ASD diagnoses over the past few decades, suggesting that ge-
netics alone cannot explain many cases of disease. If true, tar-
geted repair of an altered microbiome through interventions
including probiotics, prebiotics, or diet may represent natural,
safe, and effective treatments for neurological disorders such
as autism.
Microbiome-Mediated Alterations to Neurophysiology
The observation that GF or probiotic-treated mice have altered
behavior raises numerous interesting questions related to gut-
brain communication. Do microbially derived signals act directly
on the nervous system, or indirectly via the immune, endocrine,
or metabolic systems and/or other pathways? Is the influence of
the microbiome due to developmental effects, or is the micro-
biome-brain axis an actively modulated process? What are the
neurophysiological changes in the brain that arise due to alter-
ations to the microbiome, which may underlie behavioral
effects? Mechanisms and consequences for long distance inter-
oceptive communication between gut bacteria and the brain are
likely to be context specific and not mutually exclusive.
In some cases, there is evidence that microbiota-mediated
outcomes are required to occur during a specific time frame of
development and subsequently have irreversible downstream
neurological affects (Borre et al., 2014). In other examples,
neurological function can be actively modulated by signals
from the microbiome. For example, recolonizing adult GF
mice with a complete microbiota restores their anxiety-like
behavior to that of SPF mice, demonstrating that control ofCell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc. 569
Figure 2. Microbiome Influence on BBB Integrity
Intestinal microbes are capable of fermenting complex carbohydrates into
SCFAs.
(A) Microbially produced SCFAs signal to endothelial cells that create the BBB
and increase production of the tight junction proteins claudin-5 and occludin.
This leads to a tight and selective barrier, preventing undesired metabolites
from entering the brain parenchyma.
(B) In the absence of microbial fermentation, no SCFA signaling occurs, and
tight junction proteins are repressed. This leads to increased permeability of
the BBB and a loss of the selective barrier to serum metabolites.
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process between signals from the microbiome and the CNS
(Clarke et al., 2013). However, GF mice also display lower levels
of BDNF, serotonin (5-HT; 5-hydroxytryptamine), and specific
5-HT receptors (for instance, 5HT1A) in regions such as the
amygdala and hippocampus (Bercik et al., 2011; Clarke et al.,
2013; Diaz Heijtz et al., 2011; Neufeld et al., 2011). The levels
of these host molecules are not restored upon re-colonization
of adult mice, suggesting that certain phenotypes are likely pro-
grammed by the microbiota during fetal development or in
adolescence (Clarke et al., 2013).
Other processes are more actively modulated by the micro-
biome. It has also been observed that GF mice display an
increased rate of turnover of noradrenaline, dopamine, and
5-HT in the striatum region of the brain (Diaz Heijtz et al.,
2011). A high rate of turnover may subsequently have an effect
on steady-state levels of these neurotransmitters. Turnover of
norepinephrine and dopamine specifically may be responsible
for the increase in motor activity that is well documented in GF
mice (Diaz Heijtz et al., 2011), as these neurotransmitters have
roles in increasing blood flow to muscle and central motor con-
trol, respectively.
While alterations to the population or function of the micro-
biome may result in differential production of metabolites that
enter the periphery, it is unknown if these molecules could cross
the BBB and influence neurological function. Intriguingly, GF
mice have significantly increased permeability of the BBB,
both during fetal development and in adulthood (Braniste et al.,
2014) (Figure 2). This increase in permeability is due to lowered
expression of endothelial tight junction proteins, specifically oc-
cludin and claudin-5, in the absence of the microbiota. Interest-
ingly, mono-colonization with eitherClostridium tyrobutyricum or570 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.B. thetaiotaomicron could restore BBB integrity (and production
of tight junction expression), even in adult mice. As these species
produce SCFAs from fermentation of complex carbohydrates in
the gut, it was subsequently observed that the SCFA butyrate
was sufficient to restore BBB integrity (Braniste et al., 2014)
(Figure 2). This suggests that metabolic signals that are derived
from the gut microbiota actively and constantly influence the
physiological status of the BBB, a site quite distant from their
origin. However, it is unknown whether other SCFAs or microbi-
al-derived signals, or even microbial species, may also play a
role in influencing BBB permeability. This finding has important
implications in other physiological processes: it indicates that
serum metabolites that normally do not cross into the brain pa-
renchyma may potentially cross the BBB based on the status
of the microbiota, providing a mechanism for gut microbes to
control concentrations of numerous metabolites that can act
directly on neurological systems (Figure 2).
Regulation of Neurotransmitter Levels by the Gut
Microbiota
While it has been observed that changes to neurophysiology can
be mediated by the microbiome, the precise mechanism by
which this influence occurs is still unclear. Although altering the
permeability of the BBB would change the flux of serum metab-
olites into and out of the brain, there are potentially more direct
ways in which the microbiome can alter neurological function.
One of the most direct mechanisms could be through controlling
the concentration of various neurotransmitters, both in the brain
and in the periphery. For example, 5-HT levels in peripheral
serum are decreased in the absence of the gut microbiota (Wik-
off et al., 2009; Yano et al., 2015). This decrease corresponds to
lower levels of 5-HT metabolites and precursors in the intestinal
luminal contents and urine (Marcobal et al., 2013; Matsumoto
et al., 2012). The vast majority of 5-HT in the body (90%) is
produced by enterochromaffin cells in the gut (Gershon, 2013).
Release of 5-HT by enterochromaffin cells is necessary for
modulating colonic motility (Fukumoto et al., 2003). It has
recently been demonstrated that microbial-derived SCFAs are
capable of inducing 5-HT production by enterochromaffin cells,
in vitro and in animals (Reigstad et al., 2014; Yano et al., 2015).
Additionally, 5-HT is not known to cross the BBB, and therefore
the microbiome control of 5-HT turnover in the brain may instead
occur through alterations in 5-HT precursor levels (O’Mahony
et al., 2015; Sharon et al., 2014).
In particular, the essential amino acid tryptophan is a central
precursor to 5-HT synthesis. Tryptophan itself is generated by
the intestinal microbiota, and tryptophan present in the periphery
is capable of crossing the BBB, where it can then participate in
5-HT synthesis (O’Mahony et al., 2015; Sharon et al., 2014).
Nonetheless, even local stimulation and production of 5-HT in
the GI tract would have important effects on host physiology,
since 5-HT modulates GI motility (Berger et al., 2009). Intrigu-
ingly, 5-HT levels in the gut can be restored in GF mice following
colonization with a defined cocktail of spore-forming gut bacte-
ria (Yano et al., 2015), a process that regulates platelet aggrega-
tion and blood clotting. Non-SCFAmetabolites produced by this
microbial community stimulate gut enterochromaffin cells to
produce 5-HT, compensating for a defect in platelet activity
and coagulation (a process known to be regulated by 5-HT).
Cell Host & Microbe
ReviewConsequences of 5-HT regulation by bacteria in the intestine on
the concentration of 5-HT in the brain and on behavior in mice
remain unknown; however, the prevalent usage of SSRIs, which
increase the concentration of 5-HT (serotonin) at the synapse,
warrants interest in the potential of developing probiotic thera-
pies as an alternative treatment for major depressive disorder
and anxiety.
5-HT is not the only neurotransmitter whose concentrations
are influenced by the microbiome. Serum levels of other neuro-
transmitters are also decreased in the absence of the gut micro-
biota. Dopamine and GABA are decreased in the serum of GF
mice, and specific precursors and metabolites of these are
also altered in the intestine (Matsumoto et al., 2012; Velagapudi
et al., 2010). Exactly how gut bacteria alter the levels of these
neurotransmitters remains to be determined. Direct signals
from the microbiota to neurotransmitter-producing cells, such
as the enterochromaffin cells or even to enteric neurons and
glia, may regulate neurotransmitter production. While such sig-
naling to neurotransmitter-producing cells is one way in which
the microbiota may influence neurotransmitter concentrations,
gut-dwelling bacteria also directly produce small molecules
with potential to act as neurotransmitters. In turn, these may
act as signals to GI cells, or make their way to the periphery
and potentially the brain, and ultimately influence neurological
function.
It has been known for many years that specific species of gut
bacteria are capable of producing small molecules such as
serotonin, dopamine, norepinephrine, epinephrine, GABA, and
acetylcholine, possible bioactive neuropeptides (Wall et al.,
2014). However, it is unknown whether the microbially derived
molecules can act directly on host receptors as neurotransmit-
ters. Recently, it has been observed that the specific human
gut microbes C. sporogenes and Ruminococcus gnavus are
capable of producing the neurotransmitter tryptamine through
decarboxylation of tryptophan (Williams et al., 2014). In the brain,
tryptamine plays a role in the inhibitory response to 5-HT,
through its action on the trace amine-associated receptor, and
may modulate mood and appetite (Zucchi et al., 2006). In the
gut, tryptamine can also induce enterochromaffin cells to release
5-HT. While tryptamine can in fact cross the BBB from serum, it
is not known whether gut microbiota-produced tryptamine is
trafficked from the GI tract to the CNS and subsequently influ-
ences neurological function.
Another potential neurotransmitter that is produced by bacte-
ria present in the gut is tyramine. Multiple microorganisms,
including L. brevis and Enterococcus species, are capable of
decarboxylating tyrosine to tyramine (Lucas et al., 2003). Since
tyramine has been shown to modulate motor function in
worms, aswell as trace amine-associated receptors inmammals
(Zucchi et al., 2006), it raises the possibility that gut-microbiota-
produced tyramine may act as a modulator of neurological func-
tion as well. Similarly, 5-HT is produced by a number of gut
microbes in vitro, specifically many lactic acid bacteria (Ozogul
et al., 2012), and other human intestinal bacteria have been
shown to produce GABA (Minuk, 1986). While GABA and 5-HT
are not known to cross the BBB, intestinally derived (and there-
fore likely microbiota-derived) production of these molecules
may instead act locally on the vagus nerve or through signaling
via the periphery (Barrett et al., 2012). In the intestine, GABA isimportant for modulating motility, emptying, and secretion in
the intestine; in the periphery, it controls aspects of stress and
thermoregulation (Hyland and Cryan, 2010; Li et al., 2012;
Paredes and Agmo, 1992), suggesting that signals from the
microbiota may contribute to these diverse neurophysiological
functions.
Contrary to conventional wisdom, most neurotransmitters are
found in the gut at levels equal to or exceeding those in the brain.
Furthermore, the proportion of total body levels of various neuro-
transmitters is greater in the gut than the brain. While most of the
current data for microbial modulation of neurotransmitter pro-
duction and/or levels is available for the gut and periphery, local
neurotransmitter regulation by gut bacteria may have long dis-
tance effects on the brain. Neurotransmitters or other molecules
derived fromgutmicrobes have the potential tomodulate activity
of the vagus nerve, the primary nerve connecting the ENS to the
CNS, and subsequently influence brain function (Bravo et al.,
2011; Goehler et al., 2005). It is also possible that microbially
derived metabolites, which can act as precursors to neurotrans-
mitter production (such as tryptophan) and may cross through
the intestinal barrier and the BBB, could subsequently influence
both systemic and CNS neurotransmitter concentrations. It
is important to note, however, that many of these studies
describing neurotransmitter production by intestinal bacteria
have been performed in vitro, and thus, it is not known precisely
whether these bacteria utilize such metabolic pathways in vivo
and, if so, when these specific gut microbes produce these com-
pounds. Nevertheless, it is an interesting prospect that the intes-
tinal microbiota act to produce neurotransmitters and directly
modulate the nervous system (Lyte, 2013). Such findings open
up exciting possibilities in understanding how the microbiome
may affect function of the nervous system through the creation
of bioactive metabolites that are capable of modulating CNS ac-
tivity via several modes of gut-brain connection.
Microbial Control of Neurological Function by the
Immune System
Interactions between the microbiota and the nervous system
may be indirect. Growing data indicate that the peripheral im-
mune system can influence neurological function and behavior.
In fact, immune signaling has been shown to cause or allow pro-
gression of certain neurological disorders, including neurode-
generative diseases and psychological illness such as anxiety
and depression. One of the better-known examples of im-
mune-mediated effects on neurological function is sickness
behavior (Figure 3). This behavior is characterized by appetite
suppression, decreasedmotor activity, loss of social interaction,
and reduced cognition (Dantzer et al., 2008). Microbial-associ-
ated molecular patterns (MAMPs), such as lipopolysaccharide
(LPS), bacterial lipoprotein (BLP), flagellin, andCpGDNA, among
others, activate various cells of the immune system, particularly
innate immune cells such as macrophages, neutrophils, and
dendritic cells. Once activated, these cells produce numerous
pro-inflammatory cytokines, such as IL-1a, IL-1b, TNFa, and
IL-6, which make their way to the brain by crossing the BBB
via both diffusion and cytokine transporters. Once in the brain,
these cytokines act on receptors expressed by neurons and
glial cells, particularly microglia (brain-resident, innate immune
phagocytes), altering their activation status and physiologyCell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc. 571
Figure 3. Microbiome Modulation of Neuro-Immune Function
MAMPs derived from the intestinal microbiome can drive various aspects of
immune function in the periphery. Cytokine signals, such as TNFa, IL-1b, and
IL-6, can cross the BBB and trigger their production by the microglia. Inter-
action of these cytokines with neurons influences physiology and leads to
sickness behavior and depression.
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are capable of acting on receptors in afferent nerves, promoting
alterations in the signals leading from distant, peripheral body
sites to the CNS. Introduction of purified IL-1b and TNFa into
the brain or the periphery, as well as systemic treatment with
LPS (which induces pro-inflammatory gene expression in the
brain and periphery) is sufficient to mediate sickness behavior,
while IL-6 treatment is only capable of promoting fever, but not
behavioral attributes (Breder et al., 1994; van Dam et al., 1992)
(Figure 3). In further support of pro-inflammatory cytokinesmedi-
ating the onset of this behavior, treatment with anti-inflammatory
mediators, such as IGF-1 and IL-10, prevents sickness behavior
(Bluthe´ et al., 1999, 2006). In fact, the role of pro-inflammatory
cytokines in modulating human behavior is exemplified by the
finding that one-third of patients who have been treated with
IL-2 and IFNa (used as immunotherapy against cancer and
certain viral infections) develop major depressive disorder (Rai-
son et al., 2006).
Additionally, immune dysregulation is observed in both human
cases and animal models of ASD (Ashwood et al., 2006; Hsiao,
2013; Hsiao et al., 2012; Mead and Ashwood, 2015). In the
maternal immune activation (MIA) model of autism, a decrease
in regulatory T cells and an increase in pro-inflammatory innate
monocytes are observed in mice that display ASD symptoms.
Bone marrow transplantation from healthy donors (and subse-
quent restoration of immune function) is capable of rescuing
behavioral defects in this model (Hsiao et al., 2012). However,
given the role of the microbiota in modulating behaviors in this
model (Hsiao et al., 2013), it is interesting to consider that irradi-
ation itself may have also restored behavioral functions due to an
effect on the composition of the microbiome and/or by ‘‘reset-
ting’’ the immune system. Nonetheless, these data provide
evidence for a link between immune dysfunction and complex
social and behavioral disorders.
Exactly how pro-inflammatory cytokine signaling can mediate
alterations in neurological functions that affect behavior and572 Cell Host & Microbe 17, May 13, 2015 ª2015 Elsevier Inc.behavioral disorders is beginning to be revealed. Sickness
behavior and depressive disorders, for instance, are linked to al-
terations in 5-HT signaling. In this vein, IL-1b or TNFa treatment
stimulate 5-HT uptake through upregulation of the serotonin
transporter (SERT), decreasing the concentration of 5-HT avail-
able to signal in the synapase (Zhu et al., 2006). At the same
time, these cytokines decrease the level of 5-HT receptor
(5-HT2A) present on neurons, escalating the loss of 5-HT
signaling and likely mediating the alterations to behavior (Cai
et al., 2005) (Figure 3).
While pro-inflammatory cytokine signaling can be driven by
pathogenic microbes, some microbiota-derived signals induce
non-inflammatory cytokine pathways. For instance, in the
absence of a complete microbiota, mice exhibit a lower plasma
concentration of the cytokine granulocyte colony stimulating
factor (G-CSF) (Deshmukh et al., 2014). Plasma G-CSF is
capable of crossing the BBB and acts to stimulate neurogenesis
in the brain (Zhao et al., 2007). Thus, through stimulation of
G-CSF production, the microbiota may influence the rate of neu-
rogenesis. This could have effects not only on normal neurode-
velopmental processes where G-CSF signaling plays a role,
but also in injury and neurodegenerative disease. G-CSF is a pro-
tective factor following ischemic injury (Shyu et al., 2004) as well
as protective and therapeutic in certain models of both Parkin-
son’s and Alzheimer’s diseases (Meuer et al., 2006; Prakash
et al., 2013). Therefore, it is exciting to think that this may be
one way in which alterations to the microbiome could modulate
the outcome of these neurodegenerative diseases. Or more
intriguingly, introduction of microbes that specifically promote
G-CSF production may represent a future avenue of micro-
biota-mediated therapy to combat neurodegenerative illnesses.
Future Directions and Conclusions
While the role of the microbiome in influencing numerous as-
pects of metabolic and immunologic aspects is well established,
how indigenous microbes modulate neurological function during
health and disease is only now becoming appreciated. Here, we
have described emerging evidence for the behavioral and neuro-
physiological conditions in animal models and human studies
that have been linked to the microbiome. Rapid and sustained
growth of research on the gut-microbiome-brain connection
may lead to discoveries that prompt a reconsideration of poten-
tial environmental influences on numerous neurological diseases
whose causes have remained enigmatic and where treatment
options are limited.
Several seminal reports now show that animals lacking micro-
biota have significantly altered brain development and behavior
compared to colonized counterparts, highlighting the stark
importance of host-microbial symbiosis. GF animals provide a
valuable model to determine not only the precise physiological
processes that the microbiota influence, but also the extent of
the effects. Along with probiotic or antibiotic treatment of colo-
nized animals, GF models provide an experimental platform to
reconstitute biological systems with defined communities or sin-
gle microbial species, and from a variety of donor sources (e.g.,
genetically engineered mice, humans, etc.) allowing for the dis-
covery and functional characterization of organisms and mole-
cules that impact the nervous system. Identification of microbes
(either single species or consortia) that modulate these systems
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signals and host pathways that influence specific neurophysio-
logical function. Genomic and genetic approaches to study
newly discovered organisms, alongside metabolomic analyses
to identify products or compounds from symbiotic bacteria,
may provide critical insight into how particular microbial mole-
cules alter host neurophysiology. Accordingly, identification of
bioactive microbial signals may serve as a tool for the discovery
of currently unidentified host pathways or novel activities of
known pathways that influence behavior and neurological func-
tion, similar to how the study of bacterial pathogenesis has un-
covered the intricacies of host immune system pathways by first
identifying those microbial signals that modulate them.
It will be critical to differentiate whether the influence of themi-
crobiome on a host process is developmental or active in nature.
That is, are the signals from themicrobiota that alter neurological
function important at a specific time during development (Borre
et al., 2014), or can phenotypes be actively modulated in fully
developed animals? Are certain aspects of behavior mediated
by signals that are derived from the maternal microbiome, or
instead, can fluctuations to the composition and function of an
adult microbiome also contribute to neurological function?Given
that the majority of brain development occurs in utero, maternal
signals are likely to play a significant role. While the womb was
believed to be sterile, recent controversial observations have
called this into question and suggest microbially derived prod-
ucts may interact directly with the developing fetus (Aagaard
et al., 2014; Borre et al., 2014; Funkhouser and Bordenstein,
2013; Jime´nez et al., 2008). Furthermore, the physiological influ-
ence on maternal systems may have indirect effects on fetal
development, such as through metabolic and/or immune path-
ways (PrabhuDas et al., 2015). Several studies have recently
shed light on the relevance of the maternal-fetal interaction
and the important contribution of microbiome dynamics in the
first few years of life. There is likely not a single answer, and spe-
cific processes will likely have distinct roles for themicrobiome in
different contexts.
Perhaps one of the most pressing areas of research in the field
is understanding the physiological consequences of altered mi-
crobiome populations that correlate with certain disease states.
Do these changed populations enact a physiological effect that
drives the disease they are correlated with? In other words, are
alterations to the microbiome causal to a given condition? Or
instead, are changes to gut bacterial composition simply a
consequence of the disease state? For many neurological dis-
eases that lack a strong genetic component, environmental fac-
tors are thought to play a critical role. Further study may uncover
the microbiome as an important environmental factor that may
be an etiological agent of disease, instigating effects that have
lasting consequences on the initiation and/or progression of
neurological illness. Future studies addressing these questions
will add critical relevance to correlative associations described
to date between the microbiome and disease of the nervous
system.
As we begin to understand how microbial-derived processes
influence the brain and behavior during health and disease, we
may perhaps begin to rationally design microbiota-based thera-
peutics for neurological disorders. For example, understanding
the signals that drive neurotransmitter production by intestinalbacteria (either directly or indirectly through the production of
precursors) may provide a foundation for therapies in diseases
that are currently treated by pharmacological alteration of neuro-
transmitter levels. This could include a range of disorders, from
neurodegenerative diseases like Parkinson’s disease, which is
treated with oral L-DOPA to stimulate dopamine levels, to
depression, which is commonly treated with SSRIs that increase
the concentration of 5-HT available to signal in the synapse.
Additionally, understanding how the microbiota modulate im-
mune responses at distal sites may lead to understanding how
we can specifically alter gut microbes to influence immune-
mediated pathologies in the brain, such as those that occur dur-
ing stroke, seizures, and neurodegenerative diseases.
While microbiologists have understood for decades that mi-
crobes can alter the hosts’ behavior in various invertebrate
and vertebrate systems, it is only in the last 5 years that other
scientific communities have begun to appreciate the potential
scale and depth by which commensal microbes affect complex
neurological function in mammals. A handful of molecular
mechanisms that control these interactions have been identi-
fied; however, the field is poised to make great strides in under-
standing this new paradigm based on growing awareness of
the gut-microbiome-brain axis. Multi-disciplinary collaborations
between microbiologists, immunologists, neuroscientists and
bioinformaticians will continue to drive discovery into how sym-
biotic microbes function to shape our brains and behaviors and
how we may exploit these organisms to combat neurological
diseases. Neurodevelopmental, psychiatric, and neurodegen-
erative disorders represent some of the most serious medical
and societal burdens of our time; yet the etiologies of most dis-
orders of the brain remain unknown, and therapies are largely
either ineffective or have severe side effects. New concepts
and therapeutic modalities are desperately needed to explain
and address many neurological conditions. It appears that
future discoveries in the neurosciences will not solely rely on
studying the brain, but also surprisingly through exploration of
a forgotten organ with similar size and complexity—the human
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